Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Peter Diamandis
AddedMar 31, 2024
UpdatedJun 28, 2026
Peter Diamandis

Peter Diamandis

Co-Founder, Singularity University

CrunchbaseLinkedIn

Peter Diamandis's Career

Singularity University
Singularity University

Mountain View, CA, US

Co-Founder
Xprize
Xprize

Culver City, CA, US

Board Member· Board
Bold Capital Partners
Bold Capital Partners

Santa Monica, CA, US

Founder
Singularity University Ventures
Singularity University Ventures

Mountain View, CA, US

Co-Founder
Vaxxinity
Vaxxinity

Dallas, TX, US

Board Member· Board
Celularity
Celularity

Florham Park, NJ, US

Board Member· Board
Fountain Therapeutics
Fountain Therapeutics

Stanford, CA, US

Board Member· Board
Fountain Life
Fountain Life

Naples, FL, US

Co-Founder
Human Longevity
Human Longevity

San Diego, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Peter Diamandis's Career

Singularity University
Singularity University
Investment FirmInvestment Firm$32M6002008Mountain View, CA, US
Co-Founder

Leadership at Singularity University

Erik AndersonErik AndersonBoard Member
Pascal FinettePascal FinetteBoard Member
Eric RiesEric RiesBoard Member
Darlene DammDarlene DammBoard Member
Ketan PatelKetan PatelBoard Member
Nicholas HaanNicholas HaanBoard Member

Similar to Singularity University

Singularity University VenturesSingularity University VenturesMountain View, CA, USest. 2009Singularity University VenturesMountain View, CA, US · est. 2009

Singularity University Ventures: A leading global impact investment platform, bridging startups with investors to solve global challenges.

Investment Firm375
Founder.OrgFounder.OrgSan Francisco, CA, USest. 2012Founder.OrgSan Francisco, CA, US · est. 2012

San Francisco-based firm fostering student entrepreneurs through investment and company building.

Investment Firm20
Curious MindsCurious MindsWest Hollywood, CA, USest. 2004Curious MindsWest Hollywood, CA, US · est. 2004

Curious Minds: A tech-focused incubator, angel fund, and startup accelerator, driving innovation since 2004.

Investment Firm33
ScienceScienceSanta Monica, CA, USest. 2011ScienceSanta Monica, CA, US · est. 2011

Science partners, developing and funding disruptive tech-based companies.

Investment Firm · $72.3M236
Xprize
Xprize
NonprofitNonprofit$1.8M3541995Culver City, CA, US
Board Member· Board

Recent news

How one AI startup is helping rice farmers battle climate changeTechCrunch · 2025

Leadership at Xprize

Sony MordechaiSony MordechaiBoard Member
Daniel KraftDaniel KraftBoard Member
Anousheh AnsariAnousheh AnsariBoard Member
Naveen JainNaveen JainBoard Member
Richard GarriottRichard GarriottBoard Member
Jack BaderJack BaderBoard Member
Bold Capital Partners
Bold Capital Partners
Investment FirmInvestment Firm172015Santa Monica, CA, US
Founder

Recent news

Omeat emerges from stealth with beefy tech approach to cultivated meat growth mediaTechCrunch · 2023
Singularity University Ventures
Singularity University Ventures
Investment FirmInvestment Firm3752009Mountain View, CA, US
Co-Founder

Leadership at Singularity University Ventures

Ray KurzweilRay KurzweilCo-Founder
Monique GiggyMonique GiggyCo-Founder
Vaxxinity
Vaxxinity
Public$9.3M972019Dallas, TX, US
Board Member· Board

Leadership at Vaxxinity

George Ronald HornigGeorge Ronald HornigBoard Member
Lou ReeseLou ReeseBoard Member
Mei Mei HuMei Mei HuCo-Founder
Mei mei tongMei mei tongCEO
Celularity
Celularity
Public$400M2252016Florham Park, NJ, US
Board Member· Board

Leadership at Celularity

Jaisim ShahJaisim ShahBoard Member
Jodi GurneyJodi GurneyCo-Founder
Carlos RamirezCarlos RamirezCo-Founder
Marc MazurMarc MazurBoard Member
Dean KehlerDean KehlerBoard Member
JOHN HAINESJOHN HAINESCo-Founder

Similar to Celularity

Platelet BioGenesisPlatelet BioGenesisWatertown, MA, USCell Therapyest. 2014Platelet BioGenesisWatertown, MA, US · est. 2014

US-based PlateletBio pioneers in allogeneic cell therapy, innovating superior solutions for unmet medical challenges.

Series B · $132.1M39
Cell BioEnginesCell BioEnginesNew York City, NY, USCell Therapiesest. 2022Cell BioEnginesNew York City, NY, US · est. 2022

Cell BioEngines, Inc.: A clinical-stage biotech firm innovating cancer cures with scalable cell therapies.

Pre-Seed · $625k6
Cellular ApproachesCellular ApproachesLos Angeles, CA, USCell Therapiesest. 2016Cellular ApproachesLos Angeles, CA, US · est. 2016

Cellular Approaches: Innovating in innate immunity biotech for unmet medical needs.

Seed · $2.6M5
HebeCellHebeCellNatick, MA, USCell Therapiesest. 2016HebeCellNatick, MA, US · est. 2016

MA-based HebeCell pioneers in immuno-oncology and regenerative medicine through cell-based therapeutics.

Series A · $63M24
Fountain Therapeutics
Fountain Therapeutics
Series A$26M372018Stanford, CA, US
Board Member· Board

Leadership at Fountain Therapeutics

William GreeneWilliam GreeneCEO
Thomas RandoThomas RandoBoard Member
Joseph RodgersJoseph RodgersCo-Founder

Similar to Fountain Therapeutics

Retro BiosciencesRetro BiosciencesSan Francisco, CA, USTherapeuticsest. 2021Retro BiosciencesSan Francisco, CA, US · est. 2021

Retro Biosciences, an American medical firm, pioneers in cellular reprogramming and plasma-inspired therapeutics.

Late Stage Private · $180M44
Fountain LifeFountain LifeNaples, FL, USDiagnostics, HealthTechest. 2019Fountain LifeNaples, FL, US · est. 2019

Fountain Life: Integrated health tech provider for predictive, personalized, data-driven care.

Series B · $17.1M125
Deciduous TherapeuticsDeciduous TherapeuticsSan Francisco, CA, USTherapeuticsest. 2018Deciduous TherapeuticsSan Francisco, CA, US · est. 2018

Deciduous Therapeutics: Innovating immune-modulatory therapies to remove senescent cells, improving health-span and treating age-related diseases.

Seed · $16.5M37
Dorian therapeuticsDorian therapeuticsSan Carlos, CA, USAnti-Aging, Therapeuticsest. 2018Dorian therapeuticsSan Carlos, CA, US · est. 2018

Developing senoblockers for anti-aging, Dorian Therapeutics reactivates tissue regeneration.

Acquired · $120k
Fountain Life
Fountain Life
Series B$17.1M1252019Naples, FL, US
Co-Founder

Recent news

Whoop opens blood-testing service to what it says is a 350,000-person waitlistTechCrunch · 2025

Leadership at Fountain Life

Robert HaririRobert HaririCo-Founder
Todd WanekTodd WanekCo-Founder
Tony RobbinsTony RobbinsCo-Founder
William KappWilliam KappCEO
B.K. ModiB.K. ModiCo-Founder
Human Longevity
Human Longevity
Acquired$340.5M02013San Diego, CA, US
Board Member· Board

Leadership at Human Longevity

Richard ScheuermannRichard ScheuermannBoard Member
Robert HaririRobert HaririBoard Member
David KarowDavid KarowCEO
Max FoxMax FoxBoard Member
Bryan JohnsonBryan JohnsonBoard Member
J. Craig VenterJ. Craig VenterBoard Member

Peter Diamandis's Co-Investors

Serena WilliamsSerena WilliamsCo-invested · Lifeforce Series AScottie UpshallScottie UpshallCo-invested · Lifeforce Series AScottie UpshallScottie UpshallCo-invested · Lifeforce Series AJustin RosensteinJustin RosensteinCo-invested · Good Money Series AMitch KaporMitch KaporCo-invested · Good Money Series ABlake MycoskieBlake MycoskieCo-invested · Good Money Series AKen HoweryKen HoweryCo-invested · Good Money Series ATroy CarterTroy CarterCo-invested · Good Money Series A

Peter Diamandis's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Peter Diamandis

Mark SiegelMark SiegelBoard Member · GetaroundJackson MosesJackson MosesFounder · Silent VenturesBrad StrumBrad StrumCo-Founder · F50Jeff RichJeff RichCo-Founder · Hemisphere VenturesBarry Lynn JenkinsBarry Lynn JenkinsCo-Founder · Continuous Precision Medicine